<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02213523</url>
  </required_header>
  <id_info>
    <org_study_id>ABG AOX-1</org_study_id>
    <nct_id>NCT02213523</nct_id>
  </id_info>
  <brief_title>ABG Oxidative Stress Study Protocol-1</brief_title>
  <official_title>Proof of Concept Study to Evaluate the Effect of Oxidative Stress Response of Plant Concentrate Blends in Healthy Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Access Business Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Access Business Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a proof of concept study that evaluates the response to oxidative stress in healthy&#xD;
      men after taking plant concentrates.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sustained oxidative stress may cause hypertension, insulin resistance, metabolic syndrome,&#xD;
      cardiovascular disease and other chronic conditions. Diets rich in natural antioxidants is&#xD;
      associated with protective effects on the investigators health. The strategy to prevent&#xD;
      chronic disease development and in making up the nutritional gap in the investigators diet&#xD;
      has shifted from vitamins and minerals supplementation to whole foods and whole food&#xD;
      products.&#xD;
&#xD;
      The objectives is to evaluate the effect of oxidative stress response of plant concentrate&#xD;
      blends. Also, we'll confirm that vitamins, minerals and plant concentrates will not influence&#xD;
      the biomarker expression that were monitored in the oxidative stress biomarkers. Lastly,&#xD;
      collecting additional information on whether blends of plant concentrate have other potential&#xD;
      health benefits.&#xD;
&#xD;
      This study will test the dose-response of blends of plant concentrates. Healthy men (n=60)&#xD;
      with low fruit and vegetable intake will participate in a 32 day or 46 days. Each treatment&#xD;
      duration lasts 14 days. Microarray assay and real time-polymerase chain reaction will be&#xD;
      performed.Genes associated with oxidative stress will me monitored. The outcome of this study&#xD;
      will help us understand how to design and develop future antioxidant related products.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in urine 8-isoprostane</measure>
    <time_frame>Day 1, 15</time_frame>
    <description>Change in antioxidant biomarker from baseline to day 15</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in erythrocyte Superoxide Dismutase</measure>
    <time_frame>1, 15</time_frame>
    <description>Change in antioxidant biomarker from baseline to day 15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma malondialdehyde</measure>
    <time_frame>Day 1, 15</time_frame>
    <description>Change in antioxidant biomarker from baseline to day 15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma hemoxygenase-1</measure>
    <time_frame>Day 1, 15</time_frame>
    <description>Change in antioxidant biomarker from baseline to day 15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erythrocyte glutathione peroxidase</measure>
    <time_frame>Day 1, 15</time_frame>
    <description>Change in antioxidant biomarker from baseline to day 15</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Plant concentrate A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant concentrate A containing Rosemary:Quercetin:Turmeric 5:3:1 Low dose (300 mg) to high dose (600 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plant concentrate B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant concentrate B containing Holy Basil: Wasabi: Broccoli 5:5:1 Low dose (300 mg) to high dose (600 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plant concentrate C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant concentrate C containing Holy Basil:Rosemary:Broccoli seed:Turmeric 2:2:1:1 Low dose (300 mg) to High dose (600 mg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plant concentrate D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant concentrate D containing Rosemary:Licorice:Turmeric 1:1:1 Low dose (300 mg) to High dose (600 mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant concentrate A</intervention_name>
    <description>Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.</description>
    <arm_group_label>Plant concentrate A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant concentrate B</intervention_name>
    <description>Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.</description>
    <arm_group_label>Plant concentrate B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant concentrate C</intervention_name>
    <description>Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.</description>
    <arm_group_label>Plant concentrate C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Plant concentrate D</intervention_name>
    <description>Screening for the optimal dosage by starting with with a low dose of 300 mg for one week then switch to 600 mg for one week.</description>
    <arm_group_label>Plant concentrate D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adult men between 45-65 yr old with low fruit and vegetable intake&#xD;
&#xD;
          -  Individual with low fruit and vegetable intake and consuming fewer than 12 items found&#xD;
             on the Recommended Foods Check (RFC) (AppendixI) per week. (score &lt;12 pts)&#xD;
&#xD;
          -  Individuals with screening blood and urine laboratory values within 20% of normal&#xD;
             range indicated in the lab report (Appendix IV)&#xD;
&#xD;
          -  Individual should be judged to be in good general health on the basis of an interview&#xD;
             and abbreviated physical exam.&#xD;
&#xD;
          -  Individual understands the procedures and agrees to participate in the study.&#xD;
&#xD;
          -  Individual is willing to maintain their exercise habits and dietary pattern throughout&#xD;
             the duration of the trial.&#xD;
&#xD;
          -  Individual is willing to consume a diet or drink devoid of high content of quercetin&#xD;
             (e.g. apple and onions), rosemary, turmeric, Holy basil, wasabi, broccoli seeds, and&#xD;
             licorice thought the duration of the trial.&#xD;
&#xD;
          -  Individual is able and willing to provide written informed consent and confidentiality&#xD;
             agreement.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of dietary supplements within one week of DAy 1. Supplements include any vitamins,&#xD;
             minerals, and herbal products, including herbal drink.&#xD;
&#xD;
          -  Presence of, or clinical significant history of, cancer, cardiovascular, endocrine,&#xD;
             kidney, liver, lung, gastrointestinal, metabolic disorder, absorption disorder such as&#xD;
             Celiae or Crohn's disease and/or any other chronic health condition such as diabetes&#xD;
             identified from the finding of the interview.&#xD;
&#xD;
          -  Presence of cardiovascular disease and hypertension with inconsistent medication&#xD;
             regimen, unstable conditions, and without proper physician's supervision identified&#xD;
             from the findings fo the interview.&#xD;
&#xD;
          -  Individual who use medicines such as statins (e.g. simvastatin, fluvastatin), NSAIDS&#xD;
             including aspirin, nitric oxide *eNOS) activators or inhibitors (e.g. selegiline,&#xD;
             Viagra), and angiotensin II receptor blocker (e.g. Telmisartan (blood pressure)), and&#xD;
             take any of these medications within 10 hours prior to the blood and urine sample&#xD;
             collection.&#xD;
&#xD;
          -  Individuals who eat spicy food (e.g. capsaicin from chili pepper) and drink coffee and&#xD;
             tea including herbal teas within 10 hours prior to the blood and urine sample&#xD;
             collection.&#xD;
&#xD;
          -  Participation in another clinical trial within 30 days of enrollment into the study.&#xD;
&#xD;
          -  History of current abuse of nicotine, drugs or alcohol, or intake &gt;3 alcoholic&#xD;
             beverages per day&#xD;
&#xD;
          -  Have known allergy to the ingredients in the tested samples such as quercetin,&#xD;
             rosemary, turmeric, Holy basil, wasabi, broccoli seeds, and licorice.&#xD;
&#xD;
          -  Any condition that the principal Investigator believes amy put the subject under risk.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Keech, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southbay Pharma Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Quality of Life</name>
      <address>
        <city>Buena Park</city>
        <state>California</state>
        <zip>90620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southbay Pharma Research</name>
      <address>
        <city>Buena Park</city>
        <state>California</state>
        <zip>90620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>August 7, 2014</study_first_submitted>
  <study_first_submitted_qc>August 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2014</study_first_posted>
  <last_update_submitted>August 7, 2014</last_update_submitted>
  <last_update_submitted_qc>August 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antioxidant</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

